Thomas R. Trotter
President & Chief Executive Officer

Thomas R. Trotter joined AngioScore in August 2005 as President and CEO.

Mr. Trotter brings to AngioScore more than 30 years experience in the medical device business. Most recently, he served as President and CEO of OrthoLogic, Inc., a public orthopedics company. Prior to OrthoLogic, Mr. Trotter worked for Mallinckrodt, Inc. as President of the Critical Care Division, which included 2500 employees and over $400 million in annual revenues. He joined Mallinckrodt via the acquisition of Diamond Sensor Systems, a venture-backed medical device company in the blood chemistry analysis business, where he served as President and CEO. Previously, Mr. Trotter worked for Shiley, Inc., then a division of Pfizer, where he managed the worldwide cardiopulmonary business.

Mr. Trotter holds an MBA from Pepperdine University and a B.S. in business administration from the University of Maryland. He is also a senior fellow of the Holmes Society at Harvard University.

James B. Andrews
Sr. Vice President & Chief Financial Officer

Jim Andrews serves as Sr. Vice President and Chief Financial Officer of AngioScore.

Previously, Mr. Andrews was the Vice President, Finance and Chief Financial Officer of Orquest, Inc., an innovative medical technology company dedicated to setting new standards of care in orthopedics through biological solutions. From 1995 – 2004, Mr. Andrews held a variety of positions with Orquest and was an integral member of the team which sold Orquest to DePuy Acromed, a wholly owned subsidiary of Johnson & Johnson.

Mr. Andrews also founded Andrews and Associates, a financial management consulting firm specializing in senior management consulting in the life science industry. He started his career working four years in Big 4 public accounting where he became a Certified Public Accountant. Mr. Andrews has a B.S. in Business (specialty accounting) from the University of Colorado.

Richard P. Cassidy
Vice President, Global Sales & Marketing

Dick Cassidy serves as Vice President of Global Sales & Marketing at AngioScore.

Mr. Cassidy brings to the company over 20 years of experience in leadership roles in both Sales and Marketing in the Medical Device Business. Prior to joining AngioScore, Mr. Cassidy was Divisional Vice President of Sales for Abbott Vascular. In addition, he spent many years at Boston Scientific in senior management positions in Sales and Marketing for both the Cardiology, Peripheral and Vascular Surgery Divisions and has an extensive background in Interventional Cardiology. Mr. Cassidy holds a degree in Marketing, Communications and Advertising from the University of Missouri.

Gary Gershony, MD, FACC
Chief Medical Officer

Dr. Gary Gershony serves as the Chief Medical Officer of AngioScore, is a Co-Founder of the company, and is a practicing Interventional Cardiologist at John Muir Medical Center, Walnut Creek, CA.

Previously, Dr. Gershony was the founder of Vascular Solutions, Inc. a public medical device company. Dr. Gershony was the principal inventor of Vascular Solutions’ flagship Duett™ Vascular Sealing Device and from 1996 – 2002 Dr. Gershony served as the company’s Medical Director.

Dr. Gershony grew up in Toronto, Canada and attended the University of Toronto where he graduated from medical school in 1979 at age 23. He continued his training in internal medicine and general cardiology at the University of Toronto and The Toronto Hospital. He also served as Chief Medical Resident from 1983-1984. Dr. Gershony continued his training in invasive and interventional cardiology, serving a fellowship at Emory University in Atlanta under the auspices of Dr. Andreas Gruentzig, the inventor of coronary angioplasty. From 1994-1998, Dr. Gershony was Director of the Cardiac Catheterization Laboratories and Interventional Cardiology at the University of California, Davis, Medical Center.

Dr. Gershony is board certified in interventional cardiology and is a Fellow of the American College of Cardiology, the American Heart Association Council on Clinical Cardiology and the Society for Cardiac Angiography and Interventions. Dr. Gershony has published over 70 articles in the field of cardiology, is the author of six issued patents and has lectured widely on the latest treatments for heart disease. He also serves on the adjunct faculty of the Stanford Biodesign Innovation Program.

Kent W. Jones
Sr. Vice President, Regulatory & Quality

Kent Jones serves as Vice President of Regulatory and Quality of AngioScore.

Mr. Jones has over 27 years of experience in the medical device industry. Prior to joining AngioScore, Mr. Jones served as Senior Director of Regulatory Affairs and Quality Assurance for Avantis Medical, a Sunnyvale based start-up. Mr. Jones also held positions as Vice President of Quality, Regulatory and Clinical Affairs for Carl Zeiss Meditec and Tyco Healthcare (Covidien). Mr. Jones holds a B.S. in Biology from Winthrop University.

Samuel L. Omaleki
Sr. Vice President, Operations

Sam Omaleki serves as Vice President of Operations at AngioScore.

Mr. Omaleki has over 25 years of experience in the medical device industry. Prior to joining AngioScore, Mr. Omaleki served as Vice President of Operations at Broncus Technologies and held similar positions with Access Closure, and Radiant Medical. In addition, Mr. Omaleki worked for Advanced Cardiovascular Systems as well as Guidant. Mr. Omaleki holds a B.S. in Electrical Engineering and Biomedical Engineering from California State University at Long Beach and an M.A. in Management from the University of Redlands.